1h Free Analyst Time
The atopic dermatitis drugs market is forecast to grow by USD 6.20 billion during 2023-2028, accelerating at a CAGR of 10.87% during the forecast period. The report on the atopic dermatitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of atopic dermatitis, increasing healthcare expenditure, and strong R&D pipeline.
The atopic dermatitis drugs market is segmented as below:
By Route Of Administration
- Oral
- Topical
- Injectable
By Drug Class
- Biologics
- PDE4 inhibitors
- Corticosteroids
- Calcineurin inhibitors
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the atopic dermatitis drugs market covers the following areas:
- Atopic dermatitis drugs market sizing
- Atopic dermatitis drugs market forecast
- Atopic dermatitis drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Route of Administration
7 Market Segmentation by Drug Class
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global atopic dermatitis drugs market: AbbVie Inc., Arcutis Biotherapeutics Inc., Asana BioSciences LLC, Astellas Pharma Inc., Bausch Health Companies Inc., Bayer AG, BiomX Inc., Bristol Myers Squibb Co., Dermavant Sciences Inc., Eli Lilly and Co., Evelo Biosciences Inc., Galderma SA, Incyte Corp., LEO Pharma AS, Maruho Co. Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic partnerships and acquisitions."
According to the report, one of the major drivers for this market is the high prevalence of atopic dermatitis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Arcutis Biotherapeutics Inc.
- Asana BioSciences LLC
- Astellas Pharma Inc.
- Bausch Health Companies Inc.
- Bayer AG
- BiomX Inc.
- Bristol Myers Squibb Co.
- Dermavant Sciences Inc.
- Eli Lilly and Co.
- Evelo Biosciences Inc.
- Galderma SA
- Incyte Corp.
- LEO Pharma AS
- Maruho Co. Ltd.
- Novartis AG
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Sanofi SA
- Viatris Inc.
